Biotech & Life Sciences
Biotech Marketing
Biotech buyers scrutinise every claim. Marketing that lacks scientific rigour loses trust before the first call. We build the credibility that opens doors.
Biotech & Life Sciences
Biotech buyers scrutinise every claim. Marketing that lacks scientific rigour loses trust before the first call. We build the credibility that opens doors.
3.8×
Increase in qualified inbound from scientific buyer segments
- 3.8×
- Increase in qualified inbound from scientific buyer segments
- 58%
- Of conference leads engaged with content before the event
- 11mo
- Average to first enterprise life sciences contract from content
The real problem
Why Biotech marketing keeps failing to deliver
Scientific buyers reject marketing that lacks technical depth
Research scientists, clinical teams, and biotech procurement committees read marketing materials with the same critical lens they apply to published papers. Vague claims, imprecise language, and marketing-speak signal that a vendor doesn't understand the domain — and immediately disqualify them.
Regulatory constraints limit what can be claimed
Life sciences marketing operates under significant regulatory constraints — FDA, EMA, and country-specific rules around clinical claims, comparative effectiveness, and product communication. Most agencies don't understand these constraints and produce content that creates compliance risk.
Long sales cycles require sustained nurture at multiple levels
Biotech procurement typically involves scientists, procurement, legal, and executive stakeholders over 6–18 month cycles. Most marketing supports only the initial awareness phase, leaving the nurture and late-stage content gaps that stall deals.
What we actually do
How Heptism works for Biotech companies
Technically accurate content written for scientific audiences
We produce white papers, application notes, technical briefs, and website content that passes scrutiny from PhD-level readers. Our life sciences content is reviewed for scientific accuracy and regulatory appropriateness before publication.
SEO targeting research and procurement queries in life sciences
Researchers actively search for assay protocols, platform comparisons, and vendor evaluations. We build the organic content that captures these high-intent queries before buyers enter vendor selection.
Multi-stakeholder content for complex procurement processes
Scientific content for researchers, executive summaries for VPs and C-suite, compliance documentation for legal and procurement — we build the content library that supports the full buying committee through long procurement cycles.
Who this is for
The Biotech companies we do our best work with
Biotech reagents & instruments
Life science tool companies — reagents, instruments, consumables — targeting research institutions, pharmaceutical companies, and clinical labs globally.
Contract research & manufacturing (CRO/CMO)
Contract research organisations and contract manufacturers marketing to biotech and pharma clients across drug discovery, clinical trials, and manufacturing.
Digital health & clinical tech
Software and technology companies serving clinical research, hospital systems, and pharmaceutical companies with digital tools, platforms, and data services.
Your questions.
Honest answers.
Do not see yours? Drop us a line. A real person replies within one business day.
01Can you produce content that passes review from our scientific team?
Yes. Our life sciences content process involves subject matter expert input at briefing stage and scientific review before publication. We do not ship content that our clients' scientists would object to.
02Do you understand FDA and EMA marketing constraints?
Yes. We work within the regulatory constraints applicable to life sciences marketing — including appropriate use of clinical language, evidence standards, and the specific rules around comparative effectiveness and clinical claims in different jurisdictions.
03Can you market to both research and clinical buyers simultaneously?
Yes. Research buyers and clinical/hospital buyers have different motivations, different vocabulary, and different procurement processes. We build separate content and channel strategies for each audience within an integrated programme.
Healthcare & HealthTech
Clinical buyers, hospital procurement, and insurance decision-makers are not like other B2B buyers. They research longer, verify harder, and never buy on hype alone.
4.1×
Organic traffic growth at 12 months
Professional Services
In professional services, your reputation IS your product. Marketing has one job: make sure the right buyers find and trust you before your competitors do.
3.6×
Inbound enquiry growth at 12 months
AI & Deep Tech
AI buyers in 2026 are sceptical, informed, and tired of vague claims. The companies winning trust are the ones proving capability through specificity.
4.7×
Technical buyer inbound at 9 months
Ready to grow your business?
Let's talk.
Tell us what you are working on. We will tell you exactly what it needs. No pitch, no proposal theatre, no discovery call that leads nowhere.
hello@heptism.com·We reply within one business day